Elite Pharmaceuticals appears to be getting closer to their goal of profitability. Of course the "filler" drugs they have been selling have been solid enough to help the company get there while Elite's bigger drug developments achieve their incremental benchmarks.... Meanwhile take a look at the Co. snapshot:
- cash: $9 million
- current liabilities: $4.5 million
- quarterly revenues: $2.6 million
- quarterly net loss: $1.9 million
No comments:
Post a Comment